Effects of dextromethorphan on dopamine release in the nucleus accumbens: Interactions with morphine

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 4, 2003, Pages 803-810

  Steinmiller, Caren L ^a   Maisonneuve, Isabelle M ^a   Glick, Stanley D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Dextromethorphan; Dopamine; Microdialysis; Morphine; Nucleus accumbens; Sensitization; 3 4 nicotinic receptor

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DEXTROMETHORPHAN; DOPAMINE; HOMOVANILLIC ACID; MORPHINE;

ARTICLE; CONTROLLED STUDY; DIALYSATE; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ELECTROCHEMISTRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; DEXTROMETHORPHAN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; MORPHINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037346884     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)01080-8     Document Type: Article

References (44)

1. Barrot M., Vallee M., Gingras M.A., Le Moal M., Mayo W., Piazza P.V. The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens. Eur. J. Neurosci. 11:1999;3757-3760.
2. Borg P.J., Taylor D.A. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat. Naunyn Schmiedebergs Arch. Pharmacol. 355:1997;582-588.
3. Buckett W.R. The influence of a GABA transaminase inhibitor, gamma-vinyl GABA, on voluntary morphine consumption in the rat. Psychopharmacology. 75:1981;214-216.
4. Corrigall W.A., Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl). 99:1989;473-478.
5. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta, and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis study. J. Pharmacol. Exp. Ther. 266(1):1993;1236-1246.
6. DiChiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
7. Di Giannuario A., Pieretti S., Catalani A., Loizzo A. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats. Neurosci. Lett. 272:1999;183-186.
8. Ebert B., Thorkildsen C., Andersen S., Christrup L.L., Hjeds H. Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists. Biochem. Pharmacol. 56:1998;553-559.
9. Ericson M., Blomqvist O., Engel J.A., Soderpalm B. Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur. J. Pharmacol. 358:1998;189-196.
10. Franklin P.H., Murray T.F. High affinity [3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Mol. Pharmacol. 41:1992;134-146.
11. Gerasimov M.R., Ashby C.R. Jr., Gardner E.L., Mills M.J., Brodie J.D., Dewey S.L. Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse. 34:1999;11-19.
12. Giorgi O., Corda M.G., Carboni G., Frau V., Valentini V., Di Chiara G. Effects of cocaine and morphine in rats from two psychogenetically selected lines: a behavioral and brain dialysis study. Behav. Genet. 27:1997;537-546.
13. Glick S.D., Maisonneuve I.M., Dickinson H.A., Kitchen B.A. Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats. Eur. J. Pharmacol. 422:2001;87-90.
14. Glick S.D., Maisonneuve I.M., Kitchen B.A., Fleck M.W. Antagonism of α3β4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur. J. Pharmacol. 438:2002;99-105.
15. Hernandez S.C., Bertolino M., Xiao Y., Pringle K.E., Caruso F.S., Kellar K.J. Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors. J. Pharmacol. Exp. Ther. 293:2000;962-967.
16. Jun J.H., Schindler C.W. Dextromethorphan alters methamphetamine self-administration in the rat. Pharmacol. Biochem. Behav. 67:2000;405-409.
17. Kelley A.E., Stinus L., Iversen S.D. Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat. Behav. Brain Res. 1:1980;3-24.
18. Klein M., Musacchio J.M. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. J. Pharmacol. Exp. Ther. 251:1989;207-215.
19. Klink R., de Kerchove d'Exaerde A., Zoli M., Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 21:2001;1452-1463.
20. Levin E.D., Mead T., Rezvani A.H., Rose J.E., Gallivan C., Gross R. The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol. Behav. 71:2000;565-570.
21. Maisonneuve I.M., Keller R.W. Jr., Glick S.D. Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study. Eur. J. Pharmacol. 199:1991;35-42.
22. Maisonneuve I.M., Warner L.M., Glick S.D. Biphasic dose-related effects of morphine on dopamine release. Drug Alcohol Depend. 65:2001;55-63.
23. Marcus M.M., Mathé J.M., Nomikos G.G., Svensson T.H. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens. Neuropharmacology. 40:2001;482-490.
24. Murray T.F., Leid M.E. Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. Life Sci. 34:1984;1899-1911.
25. Nadal R., Chappell A.M., Samson H.H. Effects of nicotine and mecamylamine microinjections into the nucleus accumbens on ethanol and sucrose self-administration. Alcohol. Clin. Exp. Res. 22:1998;1190-1198.
26. Nishikawa T., Fage D., Scatton B. Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat. Brain Res. 373:1986;324-336.
27. Papke R.L., Sanberg P.R., Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 297:2001;646-656.
28. Pettit H.O., Ettenberg A., Bloom F.E., Koob G.F. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl). 84:1984;167-173.
29. Pontieri F.E., Tanda G., Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 92:1995;12304-12308.
30. Pothos E., Rada P., Mark G.P., Hoebel B.G. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566:1991;348-350.
31. Pulvirenti L., Balducci C., Koob G.F. Dextromethorphan reduces intravenous cocaine self-administration in the rat. Eur. J. Pharmacol. 321:1997;279-283.
32. Quick M.W., Ceballos R.M., Kasten M., McIntosh J.M., Lester R.A. Alpha3beta4 subunit-containing nicotinic receptors dominate function in rat medial habenula neurons. Neuropharmacology. 38:1999;769-783.
33. Rada P., Mark G.P., Pothos E., Hoebel B.G. Systemic morphine simultaneously decreases extracellular acetylcholine and increases dopamine in the nucleus accumbens of freely moving rats. Neuropharmacology. 30:1991;1133-1136.
34. Reid L.D., Glick S.D., Menkens K.A., French E.D., Bilsky E.J., Porreca F. Cocaine self-administration and naltrindole, a delta-selective opioid antagonist. NeuroReport. 6:1995;1409-1412.
35. Rose J.E., Levin E.D., Behm F.M., Westman E.C., Stein R.M., Lane J.D.et al. Combined administration of agonist-antagonist as a method of regulating receptor activation. Ann. N. Y. Acad. Sci. 757:1995;218-221.
36. Stewart J. Conditioned stimulus control of the expression of sensitization of behavioral activating effects of opiate and stimulant drugs. Gormezano I., Wasserman E.A. Learning and memory: the behavioral and biological substrates. 1992;129-151 Erlbaum, Hillsdale (NJ).
37. Sutherland R.J. The dorsal diencephalic conduction system: a review of the anatomy and functions of the habenular complex. Neurosci. Biobehav. Rev. 6:1982;1-13.
38. Szumlinski K.K., Maisonneuve I.M., Glick S.D. The potential anti-addictive agent, 18-methoxycoronaridine, blocks the sensitized locomotor and dopamine responses produced by repeated morphine treatment. Brain Res. 864:2000;13-23.
39. Watkins S.S., Epping-Jordan M.P., Koob G.F., Markou A. Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol. Biochem. Behav. 62:1999;743-751.
40. Willins D.L., Meltzer H.Y. Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Res. 781:1998;291-299.
41. Wise R.A., Bozarth M.S. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
42. Wise R.A., Leone P., Rivest R., Leeb K. Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse. 21:1995;140-148.
43. Wu D., Otton S.V., Kalow W., Sellers E.M. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat. J. Pharmacol. Exp. Ther. 274:1995;1431-1437.
44. Xi Z.X., Stein E.A. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J. Pharmacol. Exp. Ther. 290:1999;1369-1374.